These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24225128)

  • 41. Adipocytes recognize and degrade oxidized low density lipoprotein through CD36.
    Kuniyasu A; Hayashi S; Nakayama H
    Biochem Biophys Res Commun; 2002 Jul; 295(2):319-23. PubMed ID: 12150950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.
    Li N; Liu JY; Timofeyev V; Qiu H; Hwang SH; Tuteja D; Lu L; Yang J; Mochida H; Low R; Hammock BD; Chiamvimonvat N
    J Mol Cell Cardiol; 2009 Dec; 47(6):835-45. PubMed ID: 19716829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
    Anandan SK; Gless RD
    Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of AS2586114, a soluble epoxide hydrolase inhibitor, on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine.
    Ma M; Ren Q; Fujita Y; Ishima T; Zhang JC; Hashimoto K
    Pharmacol Biochem Behav; 2013 Sep; 110():98-103. PubMed ID: 23792539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ.
    Hanif A; Edin ML; Zeldin DC; Morisseau C; Nayeem MA
    PLoS One; 2016; 11(9):e0162147. PubMed ID: 27583776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.
    Liu Y; Zhang Y; Schmelzer K; Lee TS; Fang X; Zhu Y; Spector AA; Gill S; Morisseau C; Hammock BD; Shyy JY
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16747-52. PubMed ID: 16267130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epoxyeicosatrienoic acids mediate insulin-mediated augmentation in skeletal muscle perfusion and blood volume.
    Shim CY; Kim S; Chadderdon S; Wu M; Qi Y; Xie A; Alkayed NJ; Davidson BP; Lindner JR
    Am J Physiol Endocrinol Metab; 2014 Dec; 307(12):E1097-104. PubMed ID: 25336524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition.
    Davis BB; Morisseau C; Newman JW; Pedersen TL; Hammock BD; Weiss RH
    J Pharmacol Exp Ther; 2006 Feb; 316(2):815-21. PubMed ID: 16221742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.
    Chaudhary KR; Zordoky BN; Edin ML; Alsaleh N; El-Kadi AO; Zeldin DC; Seubert JM
    Prostaglandins Other Lipid Mediat; 2013; 104-105():8-17. PubMed ID: 22922020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble epoxide hydrolase inhibitors might prevent ischemic arrhythmias via microRNA-1 repression in primary neonatal mouse ventricular myocytes.
    Liu Q; Zhao X; Peng R; Wang M; Zhao W; Gui YJ; Liao CX; Xu DY
    Mol Biosyst; 2017 Feb; 13(3):556-564. PubMed ID: 28112313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
    Gurung AB; Mayengbam B; Bhattacharjee A
    Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
    Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
    Das Mahapatra A; Choubey R; Datta B
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
    Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S
    Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.
    Červenka L; Melenovský V; Husková Z; Sporková A; Bürgelová M; Škaroupková P; Hwang SH; Hammock BD; Imig JD; Sadowski J
    Physiol Res; 2015; 64(6):857-73. PubMed ID: 26047375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble Epoxide Hydrolase Inhibition by
    Overby H; Yang Y; Xu X; Graham K; Hildreth K; Choi S; Wan D; Morisseau C; Zeldin DC; Hammock BD; Wang S; Bettaieb A; Zhao L
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus.
    Jouihan SA; Zuloaga KL; Zhang W; Shangraw RE; Krasnow SM; Marks DL; Alkayed NJ
    J Cereb Blood Flow Metab; 2013 Oct; 33(10):1650-6. PubMed ID: 23899929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65.
    Li J; Liu H; Xing B; Yu Y; Wang H; Chen G; Gu B; Zhang G; Wei D; Gu P; Li M; Hu W
    J Neurooncol; 2012 Jul; 108(3):385-93. PubMed ID: 22382785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase.
    Manickam M; Pillaiyar T; Boggu P; Venkateswararao E; Jalani HB; Kim ND; Lee SK; Jeon JS; Kim SK; Jung SH
    Eur J Med Chem; 2016 Jul; 117():113-24. PubMed ID: 27092411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The apoptosis-resistance in t-AUCB-treated glioblastoma cells depends on activation of Hsp27.
    Li J; Hu W; Lan Q
    J Neurooncol; 2012 Nov; 110(2):187-94. PubMed ID: 22903412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.